GE HealthCare Technologies Inc. Common Stock
GEHC Real Time Price USDRecent trades of GEHC by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in GEHC holdings by institutional investors
Quarterly net insider trading by GEHC's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$370,000 Oct 20, 2025 Issue: Health Issues
-
$350,000 Jul 21, 2025 Issue: Health Issues
-
$550,000 Apr 21, 2025 Issue: Health Issues
-
$220,000 Jan 21, 2025 Issue: Health Issues
-
$80,000 Oct 21, 2024 Issue: Health Issues
-
$190,000 Jul 22, 2024 Issue: Health Issues
-
$190,000 Apr 22, 2024 Issue: Health Issues
-
$90,000 Jan 22, 2024 Issue: Health Issues
-
$130,000 Oct 20, 2023 Issue: Health Issues
-
$160,000 Jul 20, 2023 Issue: Health Issues
GEHC Estimated quarterly lobbying spending
GEHC Revenue by Segment or Geography
New GEHC patent grants
-
Patent Title: Radiosynthesis device Apr. 09, 2019
-
Patent Title: Radiolabelling process Jun. 19, 2018
-
Patent Title: Radiotracer compositions Jun. 05, 2018
-
Patent Title: Anti-met therapy for previously diagnosed cancer patients May. 01, 2018
-
Patent Title: Carbazole compounds for in vivo imaging Apr. 24, 2018
-
Patent Title: Enantiomeric separation and purification of 2,3,4,9-tetrahydro-1h-carbazole-4-carboxylic acid amide derivatives Nov. 14, 2017
-
Patent Title: Purification of Oct. 17, 2017
-
Patent Title: Tau imaging probe Jul. 11, 2017
-
Patent Title: Brachytherapy template adaptor Jul. 04, 2017
-
Patent Title: Stabalised Jul. 04, 2017
-
Patent Title: Automated radiolabelling method Mar. 07, 2017
-
Patent Title: Use of aniline in the radiostabilization of oxime ligation Feb. 14, 2017
-
Patent Title: Radiopharmaceutical composition Jan. 24, 2017
-
Patent Title: Asceptic dispenser Jan. 03, 2017
-
Patent Title: Peptide radiotracer compositions Jan. 03, 2017
-
Patent Title: Radioconjugation method Nov. 15, 2016
-
Patent Title: Purification of Nov. 08, 2016
-
Patent Title: Imaging neuroinflammation Nov. 01, 2016
-
Patent Title: Zinc halide mediated cyclization process leading to tricyclic indoles Oct. 25, 2016
-
Patent Title: Fluorination process Oct. 18, 2016
-
Patent Title: Pierce and fill device Oct. 18, 2016
-
Patent Title: Tau imaging probe Sep. 27, 2016
-
Patent Title: Multi-vial dispensing Sep. 06, 2016
-
Patent Title: Flow cell for radiation detector Jul. 05, 2016
-
Patent Title: Preparation of Jun. 07, 2016
-
Patent Title: Purification method May. 24, 2016
-
Patent Title: In vivo imaging method for cancer Apr. 19, 2016
-
Patent Title: Preparation of pet precursor Mar. 08, 2016
-
Patent Title: Technetium labelled peptides Feb. 16, 2016
-
Patent Title: Hyperpolarized lactate contrast agent for determination of ldh activity Feb. 16, 2016
-
Patent Title: Preparation of a 1-amino-3-hydroxy-cyclobutane-1-carboxylic acid derivative Jan. 26, 2016
-
Patent Title: Process simplification for precursor compound Jan. 19, 2016
-
Patent Title: Indole derivatives Dec. 29, 2015
-
Patent Title: Aryloxyanilide imaging agents Nov. 17, 2015
-
Patent Title: Radiotracer compositions Nov. 10, 2015
-
Patent Title: Variable-depth stereotactic surface projections Nov. 03, 2015
-
Patent Title: In vivo imaging method of mood disorders Oct. 27, 2015
-
Patent Title: Radioiodinated fatty acids Sep. 22, 2015
-
Patent Title: Fluorination process Sep. 08, 2015
-
Patent Title: Method for the synthesis of Sep. 08, 2015
-
Patent Title: Method for the synthesis of 18f-labelled molecules Jul. 21, 2015
-
Patent Title: Multi-stream high-pressure liquid chromatography module Jun. 23, 2015
-
Patent Title: Solid phase extraction method Jun. 23, 2015
-
Patent Title: Purification of precursor compound by crystallisation Jun. 23, 2015
-
Patent Title: Her2 binding peptides labeled with aluminium-[18] fluoride complexed by nota Jun. 23, 2015
-
Patent Title: Heterocyclic compounds as imaging probes of tau pathology May. 26, 2015
-
Patent Title: Fluoride processing method Mar. 17, 2015
-
Patent Title: Purification method Mar. 03, 2015
-
Patent Title: Precursor compounds and methods for making same Feb. 03, 2015
-
Patent Title: Automated radiosynthesis Feb. 03, 2015
Federal grants, loans, and purchases
Estimated quarterly amount awarded to GEHC from public contracts
Recent insights relating to GEHC
Recent picks made for GEHC stock on CNBC
ETFs with the largest estimated holdings in GEHC
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $GEHC stock a Buy, Sell, or Hold?
- What is the price target for $GEHC stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $GEHC stock?
- Who owns the most shares of $GEHC stock?
- What funds own $GEHC stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view GEHC Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
- Address Chicago, IL
- Market Cap 34.8 billion
- Employees 53,000
- Industrial Classification X-Ray Apparatus & Tubes & Related Irradiation Apparatus